Clinical Trials Directory

Trials / Conditions / Early Alzheimer's Disease

Early Alzheimer's Disease

16 registered clinical trials studyying Early Alzheimer's Disease — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingHuman Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early A
NCT07512362
Bernard (Barry) BaumelPhase 2
Not Yet RecruitingA Study to Compare Two Different Sleep Tests in Participants With No Symptoms or Early Symptoms of Alzheimer's
NCT07485153
Eli Lilly and Company—
RecruitingA Study to Evaluate the Efficacy and Safety of TTYP01 Tablets in Early Symptomatic Alzheimer's Disease
NCT07252440
Shanghai Auzone Biological Technology Co., Ltd.Phase 2
RecruitingA Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
NCT07033494
Merck Sharp & Dohme LLCPhase 2
Active Not RecruitingLong-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects
NCT06304883
Alzheon Inc.Phase 3
RecruitingEffect of Transcranial Alternating Current Stimulation(tACS) for Early Alzheimer's Disease
NCT06565143
Anhui Medical UniversityN/A
Active Not RecruitingA Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease
NCT05531656
Cognition TherapeuticsPhase 2
CompletedProof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease
NCT05161715
NewAmsterdam PharmaPhase 2
UnknownDevelopment and Evaluation of Computerized Olfactory Training Program for Cognitive Decline in Early Alzheimer
NCT05122598
Evon Medics LLCPhase 2
CompletedAn Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects
NCT04770220
Alzheon Inc.Phase 3
CompletedA Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
NCT04777409
Novo Nordisk A/SPhase 3
CompletedA Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
NCT04777396
Novo Nordisk A/SPhase 3
CompletedBiomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease
NCT04693520
Alzheon Inc.Phase 2
RecruitingHigh Definition Transcranial Direct Current Stimulation (HD-tDCS) for Early Alzheimer's Disease
NCT04599764
Anhui Medical UniversityN/A
Active Not RecruitingA Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
NCT03887455
Eisai Inc.Phase 3
CompletedA Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepat
NCT02859207
Eisai Inc.Phase 1